Biotech and Pharmaceuticals
-
Business
AbbVie taps Robert Michael as CEO, succeeding Richard Gonzalez
Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021. Dado…
Read More » -
Business
Pfizer (PFE) Q4 earnings report 2023
Pfizer CEO Albert Bourla talks during a press conference with European Commission President Ursula von der Leyen after a visit…
Read More » -
Business
Bayer wins latest Roundup cancer trial, ending losing streak
Bottles of Roundup, a brand owned by Bayer, are seen for sale in a store in New York City. June…
Read More » -
Business
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen
Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021. Dado…
Read More » -
Business
Oil and gas industry needs to let go of carbon capture as solution to climate change, IEA says
The Gorgon liquefied natural gas (LNG) and carbon capture and storage (CCS) facility, operated by Chevron Corp., on Barrow Island,…
Read More » -
Business
Goldman upgraded this mining stock and sees 25% upside on turnaround
Several tailwinds that have not been in place for a decade now make the Brazilian mining giant Vale SA too…
Read More » -
Business
Roche agrees $7.1 billion deal to buy Telavant Holdings
A photo showing the logo of Swiss pharmaceutical giant Roche in Basel. SEBASTIEN BOZON | AFP | Getty Images Swiss…
Read More » -
Business
Obesity medicine euphoria warning: Experts tackle ‘miracle drugs’
Two experts see major challenges facing the adoption of new obesity drugs. Dr. Kavita Patel, a physician and NBC News…
Read More » -
Business
Bristol-Myers Squibb to acquire Mirati in a $4.8 billion deal
Bristol-Myers Squibb is set to acquire cancer drugmaker Mirati Therapeutics for $58 per share in cash, representing a $4.8 billion…
Read More » -
Business
Federal judge denies injunction request
A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January…
Read More »